Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

What to Expect This Summer: Tariffs, Jobs, and Interest Rates

Rob Sockin, Senior Global Economist at Citi, joins J.D. Durkin to discuss tariffs, Q1 review, jobs data, and Fed rate cut expectations.

Swift Strategy: Ten Power Moves from Taylor Every Business (and Person) Can Learn From

Sinéad O’Sullivan explores ten strategic lessons from Taylor Swift’s empire in her new book Good Ideas and Power Moves—dropping September 9, 2025.

Reignited Trump-Musk feud burns Tesla investors with shares down 7%

Shares of electric vehicle maker Tesla tumbled 7% as the feud between CEO Elon Musk and Trump reignited over the weekend.

Big Business This Week: In the crypto casino, the house always wins

NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.

Nearly 368,000 pounds of turkey bacon recalled in listeria scare

The maker of Oscar Mayer turkey bacon is recalling nearly 368,000 pounds of the product because it may be contaminated with listeria bacteria.

How a rift over regulation doomed the big bill’s ban on state AI laws

A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.

Load More